Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Appointed director
|
Neos Therapeutics, Inc. (NEOS)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/19/2021 |
4
| Limongelli John M (SVP & General Counsel) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Disposed/sold 83,015 shares
@ $0 Disposed/sold 150,000 options to buy
@ $3.14, valued at
$471k
Disposed/sold 115,000 options to buy
@ $1.49, valued at
$171.4k
|
|
03/19/2021 |
4
| Robinson James A. Jr. (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Disposed/sold 23,453 shares
@ $0 Disposed/sold 12,500 options to buy
@ $2.03, valued at
$25.4k
Disposed/sold 46,907 options to buy
@ $1.44, valued at
$67.5k
|
|
03/19/2021 |
4
| McLaughlin Gerald W. (CEO) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Disposed/sold 270,171 shares
@ $0 Disposed/sold 600,000 options to buy
@ $6.2, valued at
$3.7M
Disposed/sold 392,688 options to buy
@ $2.31, valued at
$907.1k
Disposed/sold 395,000 options to buy
@ $1.49, valued at
$588.6k
Disposed/sold 100,000 options to buy
@ $5.55, valued at
$555k
Disposed/sold 65,447 options to buy
@ $2.31, valued at
$151.2k
|
|
03/19/2021 |
4
| Hecht Beth (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Disposed/sold 23,453 shares
@ $0 Disposed/sold 12,500 options to buy
@ $19.82, valued at
$247.8k
Disposed/sold 14,777 options to buy
@ $9.63, valued at
$142.3k
Disposed/sold 18,322 options to buy
@ $7.65, valued at
$140.2k
Disposed/sold 22,756 options to buy
@ $6.05, valued at
$137.7k
Disposed/sold 46,907 options to buy
@ $1.44, valued at
$67.5k
|
|
03/19/2021 |
4
| Schmid John P. (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Disposed/sold 23,453 shares
@ $0 Disposed/sold 12,500 options to buy
@ $10.73, valued at
$134.1k
Disposed/sold 14,777 options to buy
@ $9.63, valued at
$142.3k
Disposed/sold 18,322 options to buy
@ $7.65, valued at
$140.2k
Disposed/sold 22,756 options to buy
@ $6.05, valued at
$137.7k
Disposed/sold 46,907 options to buy
@ $1.44, valued at
$67.5k
|
|
03/19/2021 |
4
| Fong Bryant (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Disposed/sold 24,953 shares
@ $0 Disposed/sold 12,500 options to buy
@ $15, valued at
$187.5k
Disposed/sold 14,777 options to buy
@ $9.63, valued at
$142.3k
Disposed/sold 18,322 options to buy
@ $7.65, valued at
$140.2k
Disposed/sold 22,756 options to buy
@ $6.05, valued at
$137.7k
Disposed/sold 46,907 options to buy
@ $1.44, valued at
$67.5k
|
|
03/19/2021 |
4
| Szyper Linda M (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Disposed/sold 23,453 shares
@ $0 Disposed/sold 12,500 options to buy
@ $8.4, valued at
$105k
Disposed/sold 22,756 options to buy
@ $6.05, valued at
$137.7k
Disposed/sold 46,907 options to buy
@ $1.44, valued at
$67.5k
|
|
03/19/2021 |
4
| ROBITAILLE GREGORY J (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Disposed/sold 79,130 shares
@ $0 Disposed/sold 10,416 options to buy
@ $9.32, valued at
$97.1k
Disposed/sold 12,500 options to buy
@ $15, valued at
$187.5k
Disposed/sold 14,777 options to buy
@ $9.63, valued at
$142.3k
Disposed/sold 18,322 options to buy
@ $7.65, valued at
$140.2k
Disposed/sold 22,756 options to buy
@ $6.05, valued at
$137.7k
Disposed/sold 46,907 options to buy
@ $1.44, valued at
$67.5k
|
|
03/19/2021 |
4
| HELLER ALAN L (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Disposed/sold 446,819 shares
@ $0 Disposed/sold 12,500 options to buy
@ $15, valued at
$187.5k
Disposed/sold 14,777 options to buy
@ $9.63, valued at
$142.3k
Disposed/sold 18,322 options to buy
@ $7.65, valued at
$140.2k
Disposed/sold 22,756 options to buy
@ $6.05, valued at
$137.7k
Disposed/sold 46,907 options to buy
@ $1.44, valued at
$67.5k
|
|
03/19/2021 |
4
| Eisenstadt Richard I (CFO) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Disposed/sold 126,245 shares
@ $0 Disposed/sold 86,167 options to buy
@ $2.91, valued at
$250.7k
Disposed/sold 12,500 options to buy
@ $9.32, valued at
$116.5k
Disposed/sold 60,230 options to buy
@ $25.5, valued at
$1.5M
Disposed/sold 50,000 options to buy
@ $10.74, valued at
$537k
Disposed/sold 45,000 options to buy
@ $7, valued at
$315k
Disposed/sold 56,250 options to buy
@ $8.3, valued at
$466.9k
Disposed/sold 230,276 options to buy
@ $2.31, valued at
$531.9k
Disposed/sold 115,000 options to buy
@ $1.49, valued at
$171.4k
|
|
03/16/2021 |
4
| McLaughlin Gerald W. (CEO) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Paid exercise price by delivering 44,329 shares
@ $0.844, valued at
$37.4k
|
|
03/16/2021 |
4
| Limongelli John M (SVP & General Counsel) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Paid exercise price by delivering 16,985 shares
@ $0.844, valued at
$14.3k
|
|
03/16/2021 |
4
| Eisenstadt Richard I (CFO) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Paid exercise price by delivering 1,390 shares
@ $0.883, valued at
$1.2k
Paid exercise price by delivering 14,825 shares
@ $0.844, valued at
$12.5k
|
|
06/11/2020 |
4
| Szyper Linda M (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Granted 23,453 shares
@ $0 |
|
06/11/2020 |
4
| Schmid John P. (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Granted 23,453 shares
@ $0 |
|
06/11/2020 |
4
| ROBITAILLE GREGORY J (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Granted 23,453 shares
@ $0 |
|
06/11/2020 |
4
| Robinson James A. Jr. (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Granted 23,453 shares
@ $0 |
|
06/11/2020 |
4
| HELLER ALAN L (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Granted 23,453 shares
@ $0 |
|
06/11/2020 |
4
| Hecht Beth (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Granted 23,453 shares
@ $0 |
|
06/11/2020 |
4
| Fong Bryant (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Granted 23,453 shares
@ $0 |
|
03/16/2020 |
4
| McLaughlin Gerald W. (CEO) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Granted 100,000 options to buy
@ $5.55, valued at
$555k
Granted 65,447 options to buy
@ $2.31, valued at
$151.2k
|
|
03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/04/2020 |
4
| McLaughlin Gerald W. (CEO) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Granted 290,000 shares
@ $0 Granted 395,000 options to buy
@ $1.49, valued at
$588.6k
|
|
03/04/2020 |
4
| Eisenstadt Richard I (CFO) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Granted 100,000 shares
@ $0 Granted 115,000 options to buy
@ $1.49, valued at
$171.4k
|
|
06/17/2019 |
4
| Szyper Linda M (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Granted 46,907 options to buy
@ $1.44, valued at
$67.5k
|
|
06/17/2019 |
4
| Schmid John P. (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Granted 46,907 options to buy
@ $1.44, valued at
$67.5k
|
|
06/17/2019 |
4
| ROBITAILLE GREGORY J (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Granted 46,907 options to buy
@ $1.44, valued at
$67.5k
|
|
06/17/2019 |
4
| Robinson James A. Jr. (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Granted 46,907 options to buy
@ $1.44, valued at
$67.5k
|
|
06/17/2019 |
4
| HELLER ALAN L (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Granted 46,907 options to buy
@ $1.44, valued at
$67.5k
|
|
06/17/2019 |
4
| Hecht Beth (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Granted 46,907 options to buy
@ $1.44, valued at
$67.5k
|
|
06/17/2019 |
4
| Fong Bryant (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Granted 46,907 options to buy
@ $1.44, valued at
$67.5k
|
|
03/22/2019 |
4
| Limongelli John M (SVP & General Counsel) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Granted 150,000 options to buy
@ $3.14, valued at
$471k
|
|
03/04/2019 |
4
| McLaughlin Gerald W. (CEO) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Granted 523,583 options to buy
@ $2.31, valued at
$1.2M
|
|
03/04/2019 |
4
| Eisenstadt Richard I (CFO) has filed a Form 4 on Neos Therapeutics, Inc.
Txns:
| Granted 230,276 options to buy
@ $2.31, valued at
$531.9k
|
|
|
|
|